Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Cerebral Venous Thrombosis Workup

  • Author: W Alvin McElveen, MD; Chief Editor: Helmi L Lutsep, MD  more...
 
Updated: Oct 30, 2015
 

Approach Considerations

The diagnosis of cerebral venous thrombosis (CVT) is made on the basis of clinical presentation and imaging studies (see the images below), while clinical laboratory studies are useful for determining the possible causes of CVT.

Axial view of magnetic resonance (MR) venogram dem Axial view of magnetic resonance (MR) venogram demonstrating lack of flow in transverse sinus.
Coronal view of magnetic resonance (MR) venogram d Coronal view of magnetic resonance (MR) venogram demonstrating lack of flow in the left transverse and sigmoid sinuses.

Lab studies

A complete blood count (CBC) is performed to look for polycythemia as an etiologic factor. Decreased platelet count would support thrombotic thrombocytopenic purpura; leukocytosis might be seen in sepsis. (If heparin is used as treatment, platelet counts should be monitored for thrombocytopenia.)

Antiphospholipid and anticardiolipin antibodies should be obtained to evaluate for antiphospholipid syndrome. Other tests that may indicate hypercoagulable states include protein S, protein C, antithrombin III, lupus anticoagulant, and Leiden factor V mutation. These evaluations should not be made while the patient is on anticoagulant therapy.

Sickle cell preparation or hemoglobin electrophoresis should be obtained in individuals of African descent.

Erythrocyte sedimentation rate and antinuclear antibody studies should be performed to screen for systemic lupus erythematosus, Wegener granulomatosis, and temporal arteritis. If levels are elevated, further evaluation, including of complement levels, anti-deoxyribonucleic acid (DNA) antibodies, and neutrophil cytoplasmic antibodies (ANCA), could be considered.

Urine protein should be checked and, if elevated, nephrotic syndrome considered. Liver function studies should be performed to rule out cirrhosis.

EEG

An electroencephalogram (EEG) may be normal, show mild generalized slowing, or show focal abnormalities if a unilateral infarct occurs. An EEG is helpful in evaluating a seizure focus.

Next

Procedures

Lumbar puncture (LP) is helpful in evaluating for meningitis as an associated infectious process in cerebral venous thrombosis (CVT). However, a large, unilateral hemispheric lesion or posterior fossa lesion demonstrated on CT or MRI scan is a contraindication for LP.

In the past, compression of the jugular vein unilaterally with pressure measurement was utilized. Pressure may be elevated if thrombosis of the contralateral transverse sinus is present. However, collateral circulation or incomplete compression of the jugular vein may yield a false-negative result. Moreover, elevation of the intracranial venous pressure is a concern, as it may precipitate herniation. As the maneuver adds little to the diagnosis, it usually is not performed.

Previous
Next

D-Dimer Levels

D-dimer values may be beneficial in screening patients who present in the emergency department for headache evaluation.

In a study of 18 patients with cerebral venous thrombosis (CVT), Tardy et al reported that D-dimer levels of less than 500 ng/mL had a negative predictive value for ruling out the diagnosis in patients with acute headache.[18]

In a prospective study of 54 consecutive patients with headache suggestive of CVT, Lalive found that 12 had CVT and, of those, 10 had D-dimer levels greater than 500 ng/mL.[19] The 2 patients with confirmed CVT and a D-dimer level of less than 500 ng/mL had a history of chronic headache lasting longer than 30 days.

In a study by Kosinski et al, D-dimers were positively correlated with the extent of thrombosis and negatively correlated with the duration of symptoms in patients with cerebral sinus thrombosis. The investigators prospectively studied 343 patients with symptoms suggesting cerebral sinus thrombosis.[20] The diagnosis was confirmed in 35, with 34 of these patients showing elevated D-dimer levels greater than 500 mcg/L. Of the 308 patients not having CVT, 27 had positive values. Sensitivity was 97.1%, with a negative predictive value of 99.6%. Specificity was 91.2%, with a positive predictive value of 55.7%.

The D-dimer test does not establish the diagnosis of CVT, and more definitive studies, such as magnetic resonance venography (MRV), are necessary. Likewise, if a high suspicion for CVT exists, the test cannot definitely exclude the diagnosis but can indicate that the presence of CVT is very unlikely.

Previous
Next

CT Scanning

Computed tomography (CT) scanning is an important imaging technique, as it is often the first imaging study obtained. It may show evidence of infarction that does not correspond to an arterial distribution. However, in the absence of a hemorrhagic component, demonstration of the infarct may be delayed for as long as 48-72 hours. (See the image below.)

Computed tomography (CT) scan demonstrates a left Computed tomography (CT) scan demonstrates a left posterior temporal hematoma in a 38-year-old woman on oral contraceptives (the only identified risk factor).

CT scanning is also useful for ruling out other conditions, such as neoplasm, and in evaluating coexistent lesions, such as subdural empyema. CT scanning of the sinuses is useful in evaluating sinusitis, while CT scanning of the mastoids may be helpful in lateral sinus thrombosis.

An empty delta sign appears on contrast scans as enhancement of the collateral veins in the superior sagittal sinus (SSS) walls surrounding a nonenhanced thrombus in the sinus. However, the sign is frequently absent. Early division of the SSS can give a false delta sign. The dense triangle sign formed by fresh coagulated blood in the SSS and the cord sign representing a thrombosed cortical vein are extremely rare.

CT angiography

CT angiography has also been used to visualize the cerebral venous system. Ozsvath et al compared CT and MR projection in the identification of cerebral veins and thrombosis.[21] CT venography was superior to MR in identification of cerebral veins and dural sinuses. CT was equivalent to MR in identification of dural sinus thrombosis and therefore is a viable alternative to MRV in the examination of patients with suspected dural sinus thrombosis. The maximum-intensity-projection technique used, however, did not allow direct visualization of the thrombus by CT or MR technique.

Previous
Next

MRI

MRI shows the pattern of an infarct that does not follow the distribution of an expected arterial occlusion. It may show absence of flow void in the normal venous channels. Mas et al described MRI findings of increased intraluminal signal on all planes and with all pulse sequences in patients with lateral sinus thrombosis. (See the image below.)[22]

Contrast-enhanced magnetic resonance imaging (MRI) Contrast-enhanced magnetic resonance imaging (MRI) scan showing lack of filling of left transverse sinus.

MRV

MRV is an excellent method of visualizing the dural venous sinuses and larger cerebral veins. (See the images below.)

Left lateral sinus thrombosis demonstrated on magn Left lateral sinus thrombosis demonstrated on magnetic resonance venography (MRV). This 42-year-old woman presented with sudden onset of headache. Physical examination revealed no neurologic abnormalities.
Same patient as in the previous image. One week af Same patient as in the previous image. One week after treatment with heparin, the magnetic resonance (MR) venogram displayed increased flow in the left lateral sinus consistent with early recanalization of the sinus; headache had resolved at this point.
Magnetic resonance venogram (MRV) - axial view; A Magnetic resonance venogram (MRV) - axial view; A = lateral (transverse) sinus; B = sigmoid sinus; C = confluence of sinuses; and D = superior sagittal sinus.
Magnetic resonance venogram (MRV) - sagittal view; Magnetic resonance venogram (MRV) - sagittal view; A = lateral (transverse) sinus; C = confluence of sinuses; D = superior sagittal sinus; and E = straight sinus.

Since thunderclap headaches are not limited to SAH and may be seen with cerebral venous thrombosis (CVT), lack of evidence of SAH in a patient with such headaches should prompt examination with MRV.

SSPCA

Single-slice phase-contrast angiography (SSPCA) takes less than 30 seconds and provides rapid and reliable information. Many neurologists now consider it to be the procedure of choice in diagnosing cerebral venous thrombosis. In a study of 21 patients, Adams demonstrated a specificity and sensitivity of 100% for SSPCA when compared with alternative imaging techniques.[23]

Flow gap versus thrombosis in MRV

Ayanzen described transverse sinus flow gaps in 31% of patients with normal MRI findings who were studied with MRV; 90% of these were in the nondominant transverse sinus, and 10% were in the codominant sinuses. None was seen in the dominant sinus.[24] These should not be mistaken for thrombosis.

Previous
Next

Contrast Studies

Carotid arteriography with delayed filming technique to visualize the venous system was the procedure of choice in the diagnosis of venous thrombosis prior to the advent of MRV. It is an invasive procedure and is therefore associated with a small risk.

If MR studies are not diagnostic, conventional angiography should be considered. Direct venography can be performed by passing a catheter from the jugular vein into the transverse sinus, with injection outlining the venous sinuses.

Previous
 
 
Contributor Information and Disclosures
Author

W Alvin McElveen, MD Director, Stroke Unit, Lakewood Ranch Medical Center; Neurologist, Manatee Memorial Hospital

W Alvin McElveen, MD is a member of the following medical societies: American Academy of Neurology, Southern Clinical Neurological Society, American Stroke Association, American Medical Association, American Society of Neuroimaging

Disclosure: Nothing to disclose.

Coauthor(s)

Andrew P Keegan, MD Private Practice, Bradenton Neurology, Inc; Consulting Staff, Department of Neurology, Manatee Memorial Hospital, Lakewood Ranch Medical Center, Blake Medical Center

Andrew P Keegan, MD is a member of the following medical societies: American Academy of Neurology, American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Helmi L Lutsep, MD Professor and Vice Chair, Department of Neurology, Oregon Health and Science University School of Medicine; Associate Director, OHSU Stroke Center

Helmi L Lutsep, MD is a member of the following medical societies: American Academy of Neurology, American Stroke Association

Disclosure: Medscape Neurology Editorial Advisory Board for: Stroke Adjudication Committee, CREST2.

Acknowledgements

Ralph F Gonzalez, MD Private Practice, Bradenton Neurology, Inc; Consulting Staff, Department of Neurology, Blake Hospital, Lakewood Ranch Medical Center, Manatee Memorial Hospital

Ralph F Gonzalez, MD is a member of the following medical societies: American Academy of Neurology and Florida Medical Association

Disclosure: Nothing to disclose.

Howard S Kirshner, MD Professor of Neurology, Psychiatry and Hearing and Speech Sciences, Vice Chairman, Department of Neurology, Vanderbilt University School of Medicine; Director, Vanderbilt Stroke Center; Program Director, Stroke Service, Vanderbilt Stallworth Rehabilitation Hospital; Consulting Staff, Department of Neurology, Nashville Veterans Affairs Medical Center

Howard S Kirshner, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Neurology, American Heart Association, American Medical Association, American Neurological Association, American Society of Neurorehabilitation, National Stroke Association, Phi Beta Kappa, and Tennessee Medical Association

Disclosure: Nothing to disclose.

Norman C Reynolds Jr, MD Neurologist, Veterans Affairs Medical Center of Milwaukee; Clinical Professor, Medical College of Wisconsin

Norman C Reynolds Jr, MD is a member of the following medical societies: American Academy of Neurology, Association of Military Surgeons of the US, Movement Disorders Society, Sigma Xi, and Society for Neuroscience

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

References
  1. [Guideline] Bushnell C, McCullough LD, Awad IA, Chireau MV, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. National Guideline Clearinghouse. Available at http://guideline.gov/content.aspx?id=47871&search=cerebral+venous+thrombosis. Accessed: November 21, 2014.

  2. Cesarman-Maus G, Cantú-Brito C, Barinagarrementeria F, Villa R, Reyes E, Sanchez-Guerrero J. Autoantibodies against the fibrinolytic receptor, annexin A2, in cerebral venous thrombosis. Stroke. 2011 Feb. 42(2):501-3. [Medline].

  3. Schievink WI, Maya MM. Cerebral venous thrombosis in spontaneous intracranial hypotension. Headache. 2008 Nov-Dec. 48(10):1511-9. [Medline]. [Full Text].

  4. Canhão P, Batista P, Falcão F. Lumbar puncture and dural sinus thrombosis--a causal or casual association?. Cerebrovasc Dis. 2005. 19(1):53-6. [Medline].

  5. Ennaifer R, Moussa A, Mouelhi L, et al. Cerebral venous sinus thrombosis as presenting feature of ulcerative colitis. Acta Gastroenterol Belg. 2009 Jul-Sep. 72(3):350-3. [Medline].

  6. Towbin A. The syndrome of latent cerebral venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke. 1973 May-Jun. 4(3):419-30. [Medline].

  7. Daif A, Awada A, al-Rajeh S, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke. 1995 Jul. 26(7):1193-5. [Medline].

  8. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992 Feb. 10(1):87-111. [Medline].

  9. Galarza M, Gazzeri R. Cerebral venous sinus thrombosis associated with oral contraceptives: the case for neurosurgery. Neurosurg Focus. 2009 Nov. 27(5):E5. [Medline].

  10. Smith AG, Cornblath WT, Deveikis JP. Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology. 1997 Jun. 48(6):1613-9. [Medline].

  11. Ferro JM, Crassard I, Coutinho JM, Canhão P, Barinagarrementeria F, Cucchiara B. Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke. 2011 Oct. 42(10):2825-31. [Medline].

  12. Ferro JM, Lopes MG, Rosas MJ, et al. Long-Term Prognosis of Cerebral Vein and Dural Sinus Thrombosis. results of the venoport study. Cerebrovasc Dis. 2002. 13(4):272-8. [Medline].

  13. Buccino G, Scoditti U, Patteri I, et al. Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurol Scand. 2003 May. 107(5):330-5. [Medline].

  14. Flores-Barragan JM, Hernandez-Gonzalez A, Gallardo-Alcaniz MJ, Del Real-Francia MA, Vaamonde-Gamo J. [Clinical and therapeutic heterogeneity of cerebral venous thrombosis: a description of a series of 20 cases.]. Rev Neurol. 2009 Dec 1-15. 49(11):573-6. [Medline].

  15. Oppenheim C, Domigo V, Gauvrit JY, et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol. 2005 Mar. 26(3):614-7. [Medline].

  16. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003 May 13. 60(9):1418-24. [Medline].

  17. Wasay M, Kojan S, Dai AI, Bobustuc G, Sheikh Z. Headache in Cerebral Venous Thrombosis: incidence, pattern and location in 200 consecutive patients. J Headache Pain. 2010 Apr. 11(2):137-9. [Medline].

  18. Tardy B, Tardy-Poncet B, Viallon A, et al. D-dimer levels in patients with suspected acute cerebral venous thrombosis. Am J Med. 2002 Aug 15. 113(3):238-41. [Medline].

  19. Lalive PH, de Moerloose P, Lovblad K, et al. Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis?. Neurology. 2003 Oct 28. 61(8):1057-60. [Medline].

  20. Kosinski CM, Mull M, Schwarz M, et al. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis?. Stroke. 2004 Dec. 35(12):2820-5. [Medline].

  21. Ozsvath RR, Casey SO, Lustrin ES, et al. Cerebral venography: comparison of CT and MR projection venography. AJR Am J Roentgenol. 1997 Dec. 169(6):1699-707. [Medline].

  22. Mas JL, Meder JF, Meary E, Bousser MG. Magnetic resonance imaging in lateral sinus hypoplasia and thrombosis. Stroke. 1990 Sep. 21(9):1350-6. [Medline].

  23. Adams WM, Laitt RD, Beards SC, et al. Use of single-slice thick slab phase-contrast angiography for the diagnosis of dural venous sinus thrombosis. Eur Radiol. 1999. 9(8):1614-9. [Medline].

  24. Ayanzen RH, Bird CR, Keller PJ, et al. Cerebral MR venography: normal anatomy and potential diagnostic pitfalls. AJNR Am J Neuroradiol. 2000 Jan. 21(1):74-8. [Medline].

  25. Medel R, Monteith SJ, Crowley RW, Dumont AS. A review of therapeutic strategies for the management of cerebral venous sinus thrombosis. Neurosurg Focus. 2009 Nov. 27(5):E6. [Medline].

  26. Bentley JN, Figueroa RE, Vender JR. From presentation to follow-up: diagnosis and treatment of cerebral venous thrombosis. Neurosurg Focus. 2009 Nov. 27(5):E4. [Medline].

  27. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991 Sep 7. 338(8767):597-600. [Medline].

  28. de Bruijn SF, Stam J, Vandenbroucke JP. Increased risk of cerebral venous sinus thrombosis with third- generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group. Lancet. 1998 May 9. 351(9113):1404. [Medline].

  29. Rahman M, Velat GJ, Hoh BL, Mocco J. Direct thrombolysis for cerebral venous sinus thrombosis. Neurosurg Focus. 2009 Nov. 27(5):E7. [Medline].

  30. Ekseth K, Bostrom S, Vegfors M. Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report. Neurosurgery. 1998 Oct. 43(4):960-5. [Medline].

  31. Alonso-Canovas A, Masjuan J, Gonzalez-Valcarcel J, et al. [Cerebral venous thrombosis: when etiology makes the difference.]. Neurologia. 2009 Sep. 24(7):439-45. [Medline].

  32. Benamer HT, Bone I. Cerebral venous thrombosis: anticoagulants or thrombolyic therapy?. J Neurol Neurosurg Psychiatry. 2000 Oct. 69(4):427-30. [Medline].

  33. Cipri S, Gangemi A, Campolo C, et al. High-dose heparin plus warfarin administration in non-traumatic dural sinuses thrombosis. A clinical and neuroradiological study. J Neurosurg Sci. 1998 Mar. 42(1):23-32. [Medline].

  34. D'Alise MD, Fichtel F, Horowitz M. Sagittal sinus thrombosis following minor head injury treated with continuous urokinase infusion. Surg Neurol. 1998 Apr. 49(4):430-5. [Medline].

  35. Davis KR, Kistler JP, Buonanno FS. Clinical neuroimaging approaches to cerebrovascular diseases. Neurol Clin. 1984 Nov. 2(4):655-65. [Medline].

  36. Gold Standard Multimedia. Urokinase, Altevase, Streptokinase, Heparin, Warfarin. Clinical Pharmacology. 2000. Available at:http://cp.gsm.com/. [Full Text].

  37. Gomez CR, Misra VK, Terry JB, et al. Emergency endovascular treatment of cerebral sinus thrombosis with a rheolytic catheter device. J Neuroimaging. 2000 Jul. 10(3):177-80. [Medline].

  38. Gustafsson D, Elg M. The pharmacodynamics and pharmacokinetics of the oral direct thrombin inhibitor ximelagatran and its active metabolite melagatran: a mini-review. Thromb Res. 2003 Jul 15. 109 Suppl 1:S9-15. [Medline].

  39. Jacobs K, Moulin T, Bogousslavsky J, et al. The stroke syndrome of cortical vein thrombosis. Neurology. 1996 Aug. 47(2):376-82. [Medline].

  40. Leys D, Cordonnier C. Cerebral venous thrombosis: Update on clinical manifestations, diagnosis and management. Ann Indian Acad Neurol. 2008. 11:79-87. [Full Text].

  41. Meyer-Lindenberg A, Quenzel EM, Bierhoff E, et al. Fatal cerebral venous sinus thrombosis in heparin-induced thrombotic thrombocytopenia. Eur Neurol. 1997. 37(3):191-2. [Medline].

  42. Zweifler RM. Management of acute stroke. South Med J. 2003 Apr. 96(4):380-5. [Medline].

 
Previous
Next
 
Left lateral sinus thrombosis demonstrated on magnetic resonance venography (MRV). This 42-year-old woman presented with sudden onset of headache. Physical examination revealed no neurologic abnormalities.
Same patient as in the previous image. One week after treatment with heparin, the magnetic resonance (MR) venogram displayed increased flow in the left lateral sinus consistent with early recanalization of the sinus; headache had resolved at this point.
Magnetic resonance venogram (MRV) - axial view; A = lateral (transverse) sinus; B = sigmoid sinus; C = confluence of sinuses; and D = superior sagittal sinus.
Magnetic resonance venogram (MRV) - sagittal view; A = lateral (transverse) sinus; C = confluence of sinuses; D = superior sagittal sinus; and E = straight sinus.
Computed tomography (CT) scan demonstrates a left posterior temporal hematoma in a 38-year-old woman on oral contraceptives (the only identified risk factor).
Contrast-enhanced magnetic resonance imaging (MRI) scan showing lack of filling of left transverse sinus.
Axial view of magnetic resonance (MR) venogram demonstrating lack of flow in transverse sinus.
Coronal view of magnetic resonance (MR) venogram demonstrating lack of flow in the left transverse and sigmoid sinuses.
Table. Patients With Cerebral Venous Thrombosis Treated With Heparin and Local Infusion of Urokinase vs Nontreated Group
  Treated Group, % (n = 12) Nontreated Group, % (n = 21)
Full recovery 62.5 29
Mild disability 12.5 13
Severe disability 12.5 9.6
Fatal outcome 12.5 48
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.